Search in:

Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial

David R Coghill1 Division of Neuroscience, University of Dundee, Dundee, UKCorrespondence[email protected]

Tobias Banaschewski2 Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany

Michel Lecendreux3 Paediatric Sleep Centre and National Reference Centre for Orphan Diseases: Narcolepsy, Idiopathic Hypersomnia and Kleine-Levin Syndrome, Robert-Debré University Hospital, Paris, France

César Soutullo4 Child and Adolescent Psychiatry Unit, Department of Psychiatry and Medical Psychology, University of Navarra Clinic, Pamplona, Spain

Alessandro Zuddas5 Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy

Ben Adeyi6 Shire, Wayne, PA, USA

Shaw Sorooshian7 Shire, Eysins, Switzerland

show all

Pages 2039-2047 | Published online: 29 Oct 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

American Academy of PediatricsADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and AdolescentsPediatrics20111281007102222003063
PubMed Web of Science ®Google Scholar
WillcuttEGThe prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic reviewNeurotherapeutics20129349049922976615
PubMed Web of Science ®Google Scholar
FaraoneSVBiedermanJMickEThe age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studiesPsychol Med200636215916516420712
PubMed Web of Science ®Google Scholar
FayyadJDe GraafRKesslerRCross-national prevalence and correlates of adult attention-deficit hyperactivity disorderBr J Psychiatry200719040240917470954
PubMed Web of Science ®Google Scholar
GordonMAntshelKFaraoneSSymptoms versus impairment: the case for respecting DSM-IV’s criterion DJ Atten Disord20069346547516481663
PubMedGoogle Scholar
National Institute for Health and Clinical ExcellenceDiagnosis and management of ADHD in children, young people and adults. National Clinical Practice Guideline Number 72London, UK Available from: http://www.nice.org.uk/nicemedia/live/12061/42060/42060.pdfAccessed April 26, 2012
Google Scholar
AdlerLAGoodmanDWKollinsSHDouble-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderJ Clin Psychiatry20086991364137319012818
PubMed Web of Science ®Google Scholar
BiedermanJBoellnerSWChildressALopezFAKrishnanSZhangYLisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom studyBiol Psychiatry200762997097617631866
PubMed Web of Science ®Google Scholar
BiedermanJKrishnanSZhangYMcGoughJJFindlingRLEfficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group studyClin Ther200729345046317577466
PubMed Web of Science ®Google Scholar
CoghillDBanaschewskiTLecendreuxMEuropean, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorderEur Neuropsychopharmacol201323101208121823332456
PubMed Web of Science ®Google Scholar
FindlingRLChildressACCutlerAJEfficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry201150439540521421179
PubMed Web of Science ®Google Scholar
SoutulloCBanaschewskiTLecendreuxMA post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescentsCNS Drugs201327974375123801529
PubMed Web of Science ®Google Scholar
DuPaulGJPowerTAnastopoulosAReidRThe ADHD Rating Scale-IV, Checklist, Norms, and Clinical InterpretationNew York, NY, USAGuildford Press1998
Google Scholar
GuyWClinical Global Impressions (CGI)ECDEU Assessment Manual for PsychopharmacologyRockville, MDUS Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH, Psychopharmacology Research Branch Division of Extramural Research Programs1976
Google Scholar
CohenJA power primerPsychol Bull1992112115515919565683
PubMed Web of Science ®Google Scholar
RaderRMcCauleyLCallenECCurrent strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorderAm Fam Physician200979865766519405409
PubMed Web of Science ®Google Scholar
The MTA Cooperative GroupModerators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorderArch Gen Psychiatry199956121088109610591284
PubMed Web of Science ®Google Scholar
The MTA Cooperative GroupA 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHDArch Gen Psychiatry199956121073108610591283
PubMed Web of Science ®Google Scholar
ArnoldLEMethyiphenidate vs amphetamine: comparative reviewJ Atten Disord200034200211
Google Scholar
EliaJBorcherdingBGRapoportJLKeysorCSMethylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?Psychiatry Res19913621411552017529
PubMed Web of Science ®Google Scholar
JainRBabcockTBurteaTEfficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysisChild Adolesc Psychiatry Ment Health2011513522054243
PubMedGoogle Scholar
DittmannRWCardoENagyPEfficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb studyCNS Drugs201327121081109223959815
PubMed Web of Science ®Google Scholar
ChengJYChenRYKoJSNgEMEfficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysisPsychopharmacology (Berl)2007194219720917572882
PubMed Web of Science ®Google Scholar
AdlerLDNierenbergAAReview of medication adherence in children and adults with ADHDPostgrad Med2010122118419120107302
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date